| Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade M Ouzounova, E Lee, R Piranlioglu, A El Andaloussi, R Kolhe, ... Nature communications 8 (1), 14979, 2017 | 335 | 2017 |
| Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model R Piranlioglu, EM Lee, M Ouzounova, RJ Bollag, AH Vinyard, AS Arbab, ... Nature Communications 10 (1), 1430, 2019 | 88 | 2019 |
| Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment MH Rashid, TF Borin, R Ara, R Piranlioglu, BR Achyut, H Korkaya, Y Liu, ... Oncology Reports 45 (3), 1171-1181, 2021 | 42 | 2021 |
| The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20 E Lee, M Ouzounova, R Piranlioglu, MT Ma, M Guzel, D Marasco, ... Oncogene 38 (4), 469-482, 2019 | 27 | 2019 |
| Clinical trial links oncolytic immunoactivation to survival in glioblastoma AL Ling, IH Solomon, AM Landivar, H Nakashima, JK Woods, A Santos, ... Nature 623 (7985), 157-166, 2023 | 22 | 2023 |
| Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development MW Eunmi Lee, Raziye Piranlioglu Int. J. Mol. Sci. 2357 (20(9)), 2019 | 22 | 2019 |
| Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study S Ali, TF Borin, R Piranlioglu, R Ara, I Lebedyeva, K Angara, BR Achyut, ... PLoS One 16 (2), e0246646, 2021 | 19 | 2021 |
| Co-axial electrospraying of injectable multi-cancer drugs nanocapsules with polymer shells for targeting aggressive breast cancers M Khan, MM Hasan, A Barnett, R Piranlioglu, M Rashid, A Alptekin, ... Cancer Nanotechnology 13 (1), 6, 2022 | 7 | 2022 |
| Dietary myo-inositol chemoprevents lung carcinogenesis via boosting immune system in Kras mouse model Raziye Piranlioglu, Hasan Korkaya, Khaled A Hassan Journal of Thoracic Disease 3 (2), 2019 | 5* | 2019 |
| SOCS3 regulates IDO proteasomal degradation and inflammatory signaling in triple negative breast cancer M Ouzounova, EM Lee, E Novakovic, SK Noonepalle, R Piranlioglu, H Shi, ... Cancer Research 75 (15_Supplement), 1984-1984, 2015 | 4 | 2015 |
| Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions J Liu, R Piranlioglu, F Ye, K Shu, T Lei, H Nakashima Frontiers in Cellular and Infection Microbiology 13, 1141034, 2023 | 3 | 2023 |
| Systemic early immune priming via tumor-secreted cytokines facilitates breast cancer metastasis in syngeneic mouse model H Korkaya, E Lee, M Ouzounova, A El Andaloussi, E Novakovic, ... Cancer Research 75 (15_Supplement), 466-466, 2015 | 3 | 2015 |
| PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models M Zdioruk, JL Jimenez-Macias, MO Nowicki, KE Manz, KD Pennell, ... Cell Reports Medicine 4 (5), 2023 | 1 | 2023 |
| Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model JB Iorgulescu, N Ruthen, R Ahn, E Panagioti, PC Gokhale, M Neagu, ... Frontiers in immunology 14, 1297932, 2023 | | 2023 |
| Utilizing oncolytic virotherapy as an approach to enhance neoantigen specific immune responses in glioblastoma R Piranlioglu, R Ahn, A Islam, M Nowicki, ....., DJ Irvine, FM White, ... Neuro-Oncology 25 (Issue Supplement_5), v240, 2023 | | 2023 |
| Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models R Piranlioglu, R Ahn, H Nakashima, A Islam, R Guda, A Charest, ... The Journal of Immunology 210 (1_Supplement), 245.11-245.11, 2023 | | 2023 |
| Antigen presentation deficiency and mesenchymal differentiation underlie resistance to immunotherapy in the murine syngeneic CT2A tumor model B Iorgulescu, N Ruthen, R Ahn, E Panagioti, P Gokhale, M Neagu, ... Cancer Research 83 (7_Supplement), 2990-2990, 2023 | | 2023 |
| CTIM-09. ENRICHED TCR/BCR VDJ REARRANGEMENTS CORRELATE WITH MRI AND SURVIVAL OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA TREATED WITH CAN-3110 EA Chiocca, H Nakashima, X Mo, I Solomon, A Ling, J Woods, ... Neuro-Oncology 24 (Supplement_7), vii61, 2022 | | 2022 |
| Understanding the pro-and anti-tumorigenic microenvironments in syngeneic mice F Alkan, R Piranlioglu, E Lee, M Ouzounova, CC Hedrick, H Shi, ... Cancer Research 82 (12_Supplement), 2223-2223, 2022 | | 2022 |
| The effect of oncolytic virus therapy on neoantigen specific immune responses R Piranlioglu, J Liu, A Islam, A Ling, N Shono, WF Goins, H Nakashima, ... Cancer Research 82 (12_Supplement), 6388-6388, 2022 | | 2022 |
Hasan Korkaya, PhDGeorgia Cancer CenterVerified email at augusta.edu
